Skip to content

Eversept Partners, LP 13F Holdings · Q2 2026

Eversept Partners, LP reported 115 securities worth $1.93B in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: UTHR (8.09%), ABVX (6.32%), EHC (5.38%). Among its top 25 positions this quarter: 1 new, 12 added, 12 trimmed.

RankTickerCompanyValue% PortfolioSharesAction
1UTHRUNITED THERAPEUTICS CORP DEL$155.9M8.09%287,668Added
2ABVXABIVAX SA$121.8M6.32%913,880Trimmed
3EHCENCOMPASS HEALTH CORP$103.8M5.38%1.0MAdded
4ENSGENSIGN GROUP INC$96.5M5.01%602,079Added
5VERAVERA THERAPEUTICS INC$94.9M4.93%2.2MAdded
6QQQINVESCO QQQ TR$72.6M3.77%98,600Trimmed
7CLDXCELLDEX THERAPEUTICS INC NEW$66.5M3.45%1.8MTrimmed
8SNDXSYNDAX PHARMACEUTICALS INC$61.2M3.17%2.8MTrimmed
9BKDBROOKDALE SR LIVING INC$54.6M2.84%3.4MTrimmed
10IONSIONIS PHARMACEUTICALS INC$52.7M2.73%664,684Added
11NTRANATERA INC$47.7M2.48%175,807Trimmed
12TVTXTRAVERE THERAPEUTICS INC$45.4M2.35%798,973Added
13CTRECARETRUST REIT INC$43.3M2.24%1.1MNew
14HCAHCA HEALTHCARE INC$38.3M1.99%98,252Added
15PCVXVAXCYTE INC$36.6M1.90%629,952Trimmed
16LQDALIQUIDIA CORPORATION$34.2M1.77%428,652Trimmed
17CYHCOMMUNITY HEALTH SYS INC NEW$26.3M1.36%7.9MTrimmed
18INSMINSMED INC$26.2M1.36%245,809Added
19GSKGSK PLC$25.3M1.31%481,833Trimmed
20CHECHEMED CORP NEW$24.5M1.27%52,523Added
21LLYELI LILLY & CO$24.1M1.25%20,116Added
22GERNGERON CORP$24.0M1.24%18.7MTrimmed
23VKTXVIKING THERAPEUTICS INC$23.5M1.22%602,922Added
24OHIOMEGA HEALTHCARE INVS INC$23.1M1.20%483,547Trimmed
25PODDINSULET CORP$22.7M1.18%148,816Added

Source: SEC Form 13F filings · as of 2026-06-30

Every position in this 13F-HR, with its change from the prior quarter.

13F holdings, latest quarter

SourceSEC EDGAR13F-HR